Substance abuse among individuals with intellectual disabilities.
Abstract
Individuals with disabilities are a growing population that confronts multiple disadvantages
from social and environmental determinants of health. In particular, the 7-8 million
people in the U.S. with an intellectual disability (ID) suffer disproportionately
from substance use problems, largely because of a lack of empirical evidence to inform
prevention and treatment efforts for them. Although available research could inform
future research efforts, studies are scattered across disciplines with the last review
synthesizing findings written more than five years ago. To consider more recent findings
with earlier works, PubMed, PsychINFO, and Google Scholar were searched and produced
37 peer-reviewed texts across multiple disciplines, 15 from 2006 or later. While the
prevalence of alcohol and illicit drug use in this population are low, the risk of
having a substance-related problem among ID substance users is comparatively high.
Gaps in the research and population subgroups that warrant special attention are identified,
such as individuals with borderline and mild ID, individuals with co-occurring mental
illness, and individuals who are incarcerated. Compared with substance abusers without
ID, ID substance abusers are less likely to receive substance abuse treatment or remain
in treatment. Research is needed to better gauge the magnitude of substance use problems,
identify prevention strategies, and specify treatment components that meet the unique
needs of individuals with ID.
Type
Journal articlePermalink
https://hdl.handle.net/10161/19964Published Version (Please cite this version)
10.1016/j.ridd.2012.02.009Publication Info
Carroll Chapman, Shawna L; & Wu, Li-Tzy (2012). Substance abuse among individuals with intellectual disabilities. Research in developmental disabilities, 33(4). pp. 1147-1156. 10.1016/j.ridd.2012.02.009. Retrieved from https://hdl.handle.net/10161/19964.This is constructed from limited available data and may be imprecise. To cite this
article, please review & use the official citation provided by the journal.
Collections
More Info
Show full item recordScholars@Duke
Li-Tzy Wu
Professor in Psychiatry and Behavioral Sciences
Education/Training: Pre- and post-doctoral training in mental health service research,
psychiatric epidemiology (NIMH T32), and addiction epidemiology (NIDA T32) from Johns
Hopkins University School of Public Health (Maryland); Fellow of the NIH Summer Institute
on the Design and Conduct of Randomized Clinical Trials.Director: Duke Community Based
Substance Use Disorder Research Program.Research interests: COVID-19, Opioid misuse,
Opioid overdose, Opioid use disorder

Articles written by Duke faculty are made available through the campus open access policy. For more information see: Duke Open Access Policy
Rights for Collection: Scholarly Articles
Works are deposited here by their authors, and represent their research and opinions, not that of Duke University. Some materials and descriptions may include offensive content. More info